Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Peptic Ulcer

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 114 articles: HTML format

Single Articles

June 2009
1. PEURA DA , Riff DS, Snoddy AM, Fennerty MB, et al
   Clinical trial: Lansoprazole 15 or 30 mg once daily vs placebo for treatment of frequent nighttime heartburn in self-treating subjects.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   
2. FRAZZONI M , Savarino E, Manno M, Melotti G, et al
   A study using impedance-pH monitoring off and on proton pump inhibitor therapy.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. SADIC J , Borgstrom A, Manjer J, Toth E, et al
   Bleeding peptic ulcer - time trends in incidence, treatment and mortality in Sweden.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   May 2009
4. TSENG GY , Fang CT, Lin HJ, Yang HB, et al
   Efficacy of intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uremia: a case-control study.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   
5. FURUTA T , Kodaira C, Nishino M, Yamade M, et al
   [(13)C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   
6. YUAN YH , Wang C, Yuan Y, H Hunt R, et al
   Meta-analysis: Incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo-controlled NSAIDs trials.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   April 2009
7. SPECHLER SJ , Barker PN, Silberg DG
   Intragastric acid control in patients who have Barrett's esophagus: comparison of once- and twice-daily regimens of esomeprazole and lansoprazole.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   
8. LEE ES , Kim N, Lee SH, Park YS, et al
   Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive esophagitis and non-erosive reflux disease.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   
9. FASS R , Chey WD, Zakko SF, Andhivarothai N, et al
   Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with nonerosive reflux disease.
   Aliment Pharmacol Ther. 2009.
   PubMed     Related articles    Abstract available
   
   
   March 2009
10. FRESTON JW , Hisada M, Peura DA, Haber MM, et al
    The clinical safety of long-term lansoprazole for the maintenance of healed erosive esophagitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
11. ETMINAN M , Levesque L, Fitzgerald JM, Brophy JM, et al
    Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    February 2009
12. METZ DC , Vakily M, Dixit T, Mulford D, et al
    Dual Delayed Release Formulation of Dexlansoprazole MR, A Novel Approach to Overcome the Limitations of Conventional Single Release Proton Pump Inhibitor Therapy.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
13. LEE RD , Vakily M, Mulford D, Wu J, et al
    The Effect and Timing of Food on the Pharmacokinetics and Pharmacodynamics of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor: Evidence for Dosing Flexibility.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
14. NAM SY , Choi IJ, Nam BH, Park KW, et al
    Obesity and weight gain as risk factors for erosive esophagitis in men.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
15. SUNG JJ , Kuipers EJ, El-Serag HB
    Systematic review: update on the global incidence and prevalence of peptic ulcer disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
16. METZ DC , Howden CW, Perez MC, Larsen L, et al
    Clinical Trial: Dexlansoprazole MR, a proton pump inhibitor with Dual Delayed Release technology, effectively controls symptoms and prevents relapse in patients with healed erosive esophagitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
17. EGGLESTON A , Katelaris PH, Nandurkar S, Thorpe P, et al
    Clinical trial: The treatment of gastro-oesophageal reflux disease in primary care - prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
18. TOLIA V , Vandenplas Y
    Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children.
    Aliment Pharmacol Ther. 2009;29:258-72.
    PubMed     Related articles    Abstract available
    
    
    January 2009
19. SKINNER BJ , Gray JR, Attara GP
    Increased health costs from mandated Therapeutic Substitution of proton pump inhibitors in British Columbia.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
20. GOH KL , Wong HT, Lim CH, Rosaida MS, et al
    Time trends in peptic ulcer, erosive reflux esophagitis, gastric and esophageal cancers in a multiracial asian population.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    
21. SHARMA P , Shaheen NJ, Perez MC, Pilmer BL, et al
    Healing of erosive oesophagitis with TAK-390MR, a proton pump inhibitor with a novel dual delayed-release formulation - results from two randomized controlled studies.
    Aliment Pharmacol Ther. 2009.
    PubMed     Related articles    Abstract available
    
    
    December 2008
22. NOCON M , Labenz J, Jaspersen D, Leodolter A, et al
    Health-related quality of life in patients with gastroesophageal reflux disease under routine care - 5-years follow-up results of the proGERD study.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
23. HOLTMANN G , Chassany O, Devault KR, Schmitt H, et al
    International validation of a health related quality of life (HRQoL) questionnaire in patients with erosive gastroesophageal reflux disease (GERD).
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
24. DALTON BR , Lye-Maccannell T, Henderson EA, Maccannel DR, et al
    Proton Pump Inhibitors (PPI) significantly increase the risk of Clostridium difficile infection in a Low Endemicity, Non-outbreak Hospital Setting: optimizing risk and benefit of PPI therapy.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    November 2008
25. VAN RENSBURG C , Barkun AN, Racz I, Fedorak R, et al
    Intravenous pantoprazole versus ranitidine for the prevention of PEPTIC ulcer rebleeding: a multicenter, multinational, randomized trial.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
26. VAN BOXEL OS , Hagenaars MP, Smout AJ, Siersema PD, et al
    Sociodemographic factors influence chronic proton pump inhibitor use in a large population in the Netherlands.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
27. EL-SERAG H , Hill C, Jones R
    Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care - a review of studies using the UK General Practice Research Database.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
28. RAGHUNATH AS , Hungin AP, Mason J, Jackson W, et al
    Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
29. MIZYED I , Fass SS, Fass R
    Gastroesophageal reflux disease and psychological comorbidity.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    October 2008
30. VAN VLIET EP , Steyerberg EW, Otten HJ, Rudolphus A, et al
    The effect of guideline implementation for proton pump inhibitor (PPI) prescription on two pulmonary medicine wards.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
31. ZHANG YY , Xia HH, Zhuan ZH, Zhong J, et al
    Review article: "True" re-infection of Helicobacter pylori after successful eradication: worldwide annual rates, risk factors and clinical implications.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
32. CONCHILLO JM , Smout AJ
    Review article: Intraesophageal impedance monitoring for the assessment of bolus transit and gastroesophageal reflux.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    September 2008
33. MASON JM , Raghunath AS, Hungin AP, Jackson W, et al
    Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
34. VAKIL N , Zullo A, Ricci C, Hassan C, et al
    Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    August 2008
35. FUJINAMI H , Kudo T, Miyazaki T, Hosokawa A, et al
    Clinical trial: modified glucose clearance test: a novel non-invasive method for differentiating non-erosive reflux disease and erosive esophagitis.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
36. THIRUMURTHI S , Desilva R, Castillo DL, Richardson P, et al
    Identification of Helicobacter pylori infected patients using administrative data.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
37. CUTLER AG
    Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding: author's reply.
    Aliment Pharmacol Ther. 2008;28:500-1.
    PubMed     Related articles   
    
    
    
38. GISBERT JP , Calvet X, Feu F, Bory F, et al
    Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
    Aliment Pharmacol Ther. 2008;28:499-500.
    PubMed     Related articles   
    
    
    
39. LANZA FL , Marathi UK, Anand BS, Lichtenberger LM, et al
    Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.
    Aliment Pharmacol Ther. 2008;28:431-42.
    PubMed     Related articles    Abstract available
    
    
    
40. MULLIN JM , Valenzano MC, Whitby M, Lurie D, et al
    Esomeprazole induces upper gastrointestinal tract transmucosal permeability (R2).
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
41. OLSEN KM , Devlin JW
    Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients.
    Aliment Pharmacol Ther. 2008;28:326-33.
    PubMed     Related articles    Abstract available
    
    
    July 2008
42. RUZINEWSKI P , Soufflet C, Barthelemy P
    Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
43. VILLORIA A , Garcia P, Calvet X, Gisbert JP, et al
    Meta-analysis: High-dose proton pump inhibitors versus standard dose in triple therapy for Helicobacter pylori eradication.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
44. S TAHA A , Angerson WJ, Prasad R, McCloskey C, et al
    The incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and non-steroidal anti-inflammatory drugs.
    Aliment Pharmacol Ther. 2008.
    PubMed     Related articles    Abstract available
    
    
    
45. CHRISTIANSEN C , Christensen S, Riis A, Thomsen RW, et al
    Antipsychotic drugs and short-term mortality after peptic ulcer perforation: A population-based cohort study.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. ARMSTRONG D
    Systematic review: persistence and severity in gastroesophageal reflux disease.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. TARGOWNIK LE , Metge CJ, Leung S
    Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.
    Aliment Pharmacol Ther. 2008;28:88-96.
    PubMed     Related articles    Abstract available
    
    
    June 2008
48. MASSO GONZALEZ EL , Garcia Roderiguez LA
    Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
49. CALABRESE C , Liguori G, Gabusi V, Gionchetti P, et al
    96-hour wireless esophageal pH-monitoring following proton pump inhibitor administration in NERD patients.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. OLSEN KM , Devlin JW
    Comparison of enteral and intravenous lansoprazole pharmacodynamic response in critically ill patients.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    April 2008
51. HUNT RH , Armstrong D, Yaghoobi M, James C, et al
    Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
52. DE JONGE PJ , Siersema PD, van Breda SG, van Zoest KP, et al
    Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
53. SOEST EM , Dieleman JP, Sturkenboom MC, Siersema PD, et al
    Gastro-oesophageal reflux, medical resource utilisation and upper gastrointestinal endoscopy in patients at risk of oesophageal adenocarcinoma.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. PACE F , Pallotta S, Tonini M, Vakil N, et al
    Systematic review; gastroesophageal reflux disease and dental lesions.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
55. CHASSANY O , Holtmann G, Malagelada J, Gebauer U, et al
    Systematic Review: A Systematic Review of Health-Related Quality of Life (HRQOL) Questionnaires in Gastroesophageal Reflux Disease (GERD).
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. YEOMANS ND , Naesdal J
    Systematic review: ulcer definition in NSAID ulcer prevention trials.
    Aliment Pharmacol Ther. 2008;27:465-72.
    PubMed     Related articles    Abstract available
    
    
    February 2008
57. WAHLQVIST P , Karlsson M, Johnson D, Carlsson J, et al
    Relationship between symptom load of gastroesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
58. HIRSCHOWITZ BI , Worthington J, Mohnen J
    Vitamin b12 deficiency in hypersecretors during long-term acid suppression with proton-pump inhibitors.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. RUBIN G , Uebel P, Brimo-Hayek A, Hey KH, et al
    Validation of a brief symptom questionnaire (ReQuest in Practice(trade mark)) for patients with gastroesophageal reflux disease (GERD).
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
60. GLUUD LL , Klingenberg SL, Langholz SE
    Tranexamic acid for upper gastrointestinal bleeding: systematic review of randomised trials.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
61. SUNG JJ , Mossner J, Barkun A, Kuipers EJ, et al
    Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of the Peptic Ulcer Bleed study.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
62. GALMICHE JP , Zerbib F, Bruley des Varannes S
    Review article: respiratory manifestations of gastro-oesophageal reflux disease (GORD).
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
63. NOJKOV B , Rubenstein J, Adlis S, Shaw M, et al
    Predictors of response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: the impact of co-morbidities on treatment outcomes and quality of life.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. DEN ELZEN WP , Groeneveld Y, De Ruijter W, Souverijn JH, et al
    Long-term use of proton pump inhibitors (PPIs) and vitamin B12 status in elderly individuals.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
65. PISEGNA JR , Sostek MB, Monyak JT, Miner PB Jr, et al
    Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg in controlling intragastric acidity in healthy adults.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. DE VRIES AC , Kuipers EJ
    Review article: Helicobacter pylori eradication for the prevention of gastric cancer.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:25-35.
    PubMed     Related articles    Abstract available
    
    
    
67. OUDKERK POOL M
    Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:13-6.
    PubMed     Related articles    Abstract available
    
    
    
68. SMOUT AJ
    Review article: The measurement of non-acid gastro-oesophageal reflux.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:7-12.
    PubMed     Related articles    Abstract available
    
    
    
69. SCHWARTZ MP , Smout AJ
    Review article: The endoscopic treatment of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:1-6.
    PubMed     Related articles    Abstract available
    
    
    November 2007
70. HILLMAN LC , Chiragakis L, Shadbolt B, Kaye GL, et al
    Effect of proton pump inhibitors on markers of risk for high grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. DEAN BB , Aguilar D, Johnson LF, McGuigan JE, et al
    Nighttime and daytime atypical manifestations of gastroesophageal reflux disease: frequency, severity, and impact on health-related quality of life.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. FORD AC , Forman D, Nathan J, Crocombe WD, et al
    Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
    Aliment Pharmacol Ther. 2007;26:1267-75.
    PubMed     Related articles    Abstract available
    
    
    
73. JANIAK P , Thumshirn M, Menne D, Fox M, et al
    Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis - a randomized controlled, cross-over trial.
    Aliment Pharmacol Ther. 2007;26:1259-65.
    PubMed     Related articles    Abstract available
    
    
    October 2007
74. TYTGAT GN , McColl K, Tack J, Holtmann G, et al
    New algorithm for the treatment of gastroesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. TAHA AS , Angerson WJ, Prasad R, McCloskey C, et al
    Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin.
    Aliment Pharmacol Ther. 2007;26:1171-8.
    PubMed     Related articles    Abstract available
    
    
    
76. GOLDSTEIN JL , Johanson JF, Hawkey CJ, Suchower LJ, et al
    Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole.
    Aliment Pharmacol Ther. 2007;26:1101-11.
    PubMed     Related articles    Abstract available
    
    
    
77. JANSSON C , Nordenstedt H, Wallander MA, Johansson S, et al
    Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based study.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. MOKI F , Kusano M, Mizuide M, Shimoyama Y, et al
    Association between reflux oesophagitis and features of the metabolic syndrome in Japan.
    Aliment Pharmacol Ther. 2007;26:1069-75.
    PubMed     Related articles    Abstract available
    
    
    
79. YEE YK , Cheung TK, Chu KM, Chan CK, et al
    Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection.
    Aliment Pharmacol Ther. 2007;26:1063-7.
    PubMed     Related articles    Abstract available
    
    
    
80. SINGH M , Dhindsa G, Friedland S, Triadafilopoulos G, et al
    Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas.
    Aliment Pharmacol Ther. 2007;26:1051-61.
    PubMed     Related articles    Abstract available
    
    
    September 2007
81. VAN DER POORTEN D , Katelaris PH
    The effectiveness of rifabutin triple therapy for difficult to eradicate Helicobacter pylori in clinical practice.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. BECKER V , Bajbouj M, Waller K, Schmid RM, et al
    Clinical Trial: persistent gastroesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. FORNARI F , Blondeau K, Durand L, Rey E, et al
    Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. TSENG GY , Lin HJ, Fang CT, Yang HB, et al
    Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.
    Aliment Pharmacol Ther. 2007;26:925-33.
    PubMed     Related articles    Abstract available
    
    
    
85. BROOK RA , Wahlqvist P, Kleinman NL, Wallander MA, et al
    Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States.
    Aliment Pharmacol Ther. 2007;26:889-98.
    PubMed     Related articles    Abstract available
    
    
    
86. HIRSCHOWITZ BI , Worthington J, Mohnen J, Haber M, et al
    Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
    Aliment Pharmacol Ther. 2007;26:869-78.
    PubMed     Related articles    Abstract available
    
    
    
87. FURUTA T , Sugimoto M, Shirai N, Matsushita F, et al
    Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.
    Aliment Pharmacol Ther. 2007;26:693-703.
    PubMed     Related articles    Abstract available
    
    
    
88. JANSSON C , Nordenstedt H, Wallander MA, Johansson S, et al
    Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study.
    Aliment Pharmacol Ther. 2007;26:683-91.
    PubMed     Related articles    Abstract available
    
    
    
89. TALLEY NJ , Vakil N, Lauritsen K, VAN Zanten SV, et al
    Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?
    Aliment Pharmacol Ther. 2007;26:673-82.
    PubMed     Related articles    Abstract available
    
    
    
90. VAN ZANTEN SV , Flook N, Talley NJ, Vakil N, et al
    One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.
    Aliment Pharmacol Ther. 2007;26:665-72.
    PubMed     Related articles    Abstract available
    
    
    August 2007
91. SIERRA F , Suarez M, Rey M, Vela MF, et al
    Systematic review: proton pump inhibitor-associated acute interstitial nephritis.
    Aliment Pharmacol Ther. 2007;26:545-53.
    PubMed     Related articles    Abstract available
    
    
    
92. GISBERT JP , Fernandez-Bermejo M, Molina-Infante J, Perez-Gallardo B, et al
    First-line triple therapy with levofloxacin for Helicobacter pylori eradication.
    Aliment Pharmacol Ther. 2007;26:495-500.
    PubMed     Related articles    Abstract available
    
    
    
93. JUNG HK , Halder S, McNally M, Locke Iii GR, et al
    Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.
    Aliment Pharmacol Ther. 2007;26:453-61.
    PubMed     Related articles    Abstract available
    
    
    
94. FISCHBACH L , Evans EL
    Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Aliment Pharmacol Ther. 2007;26:343-57.
    PubMed     Related articles    Abstract available
    
    
    
95. ANAGNOSTOPOULOS GK , Yao K, Kaye P, Hawkey CJ, et al
    Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging.
    Aliment Pharmacol Ther. 2007;26:501-7.
    PubMed     Related articles    Abstract available
    
    
    July 2007
96. VAN SOEST EM , Sturkenboom MC, Dieleman JP, Verhamme KM, et al
    Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.
    Aliment Pharmacol Ther. 2007;26:265-75.
    PubMed     Related articles    Abstract available
    
    
    
97. HOGAN D , Pratha V, Riff D, Ducker S, et al
    Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro-oesophageal reflux disease and a history of erosive oesophagitis.
    Aliment Pharmacol Ther. 2007;26:249-56.
    PubMed     Related articles    Abstract available
    
    
    
98. BOECKXSTAENS GE
    Review article: the pathophysiology of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;26:149-60.
    PubMed     Related articles    Abstract available
    
    
    
99. MIWA H , Sasaki M, Furuta T, Koike T, et al
    Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.
    Aliment Pharmacol Ther. 2007;26:69-77.
    PubMed     Related articles    Abstract available
    
    
    
100. CONCHILLO JM , Schwartz MP, Selimah M, Samsom M, et al
     Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux disease.
     Aliment Pharmacol Ther. 2007;26:61-8.
     PubMed     Related articles    Abstract available
     
     
     
101. DICKMAN R , Parthasarathy S, Malagon IB, Jones P, et al
     Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.
     Aliment Pharmacol Ther. 2007;26:41-8.
     PubMed     Related articles    Abstract available
     
     
     
102. PACE F , Tonini M, Pallotta S, Molteni P, et al
     Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'
     Aliment Pharmacol Ther. 2007;26:195-204.
     PubMed     Related articles    Abstract available
     
     
     June 2007
103. BARDHAN KD , Achim A, Riddermann T, Pfaffenberger B, et al
     A clinical trial comparing pantoprazole and esomeprazole to explore the concept of achieving 'complete remission' in gastro-oesophageal reflux disease.
     Aliment Pharmacol Ther. 2007;25:1461-9.
     PubMed     Related articles    Abstract available
     
     
     
104. MANUEL D , Cutler A, Goldstein J, Fennerty MB, et al
     Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications.
     Aliment Pharmacol Ther. 2007;25:1423-7.
     PubMed     Related articles    Abstract available
     
     
     
105. VAKIL N
     Review article: the role of surgery in gastro-oesophageal reflux disease.
     Aliment Pharmacol Ther. 2007;25:1365-72.
     PubMed     Related articles    Abstract available
     
     
     
106. JONES R , Coyne K, Wiklund I
     The Gastro-oesophageal Reflux Disease Impact Scale: a patient management tool for primary care.
     Aliment Pharmacol Ther. 2007;25:1451-1459.
     PubMed     Related articles    Abstract available
     
     
     
107. ZULLO A , Perna F, Hassan C, Ricci C, et al
     Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy.
     Aliment Pharmacol Ther. 2007;25:1429-1434.
     PubMed     Related articles    Abstract available
     
     
     
108. LEMBO A , Zaman M, Jones M, Talley NJ, et al
     Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study.
     Aliment Pharmacol Ther. 2007;25:1343-50.
     PubMed     Related articles    Abstract available
     
     
     May 2007
109. MUNK EM , Drewes AM, Gorst-Rasmussen A, Gregersen H, et al
     Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10-year Danish cohort study.
     Aliment Pharmacol Ther. 2007;25:1203-10.
     PubMed     Related articles    Abstract available
     
     
     
110. KUWAYAMA H , Asaka M, Sugiyama T, Fukuda Y, et al
     Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan.
     Aliment Pharmacol Ther. 2007;25:1105-13.
     PubMed     Related articles    Abstract available
     
     
     April 2007
111. CHRISTENSEN S , Riis A, Norgaard M, Thomsen RW, et al
     Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer.
     Aliment Pharmacol Ther. 2007;25:907-12.
     PubMed     Related articles    Abstract available
     
     
     March 2007
112. COTE GA , Ferreira MR, Rozenberg-Ben-Dror K, Howden CW, et al
     Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center.
     Aliment Pharmacol Ther. 2007;25:709-14.
     PubMed     Related articles    Abstract available
     
     
     
113. KATZ PO , Ginsberg GG, Hoyle PE, Sostek MB, et al
     Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.
     Aliment Pharmacol Ther. 2007;25:617-28.
     PubMed     Related articles    Abstract available
     
     
     November 2006
114. MOROCUTTI A , Merrouche M, Bjaaland T, Humphries T, et al
     An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
     Aliment Pharmacol Ther. 2006;24:1439-44.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: